Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Protara Therapeutics, Inc. (PRTO) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/03/2023 8-K Quarterly results
Docs: "Protara Therapeutics Announces Second Quarter 2023 Financial Results and Business Update"
06/08/2023 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
05/04/2023 8-K Quarterly results
05/02/2023 8-K Quarterly results
04/28/2023 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "Protara Therapeutics Announces Positive Preliminary Data from ADVANCED-1 Phase 1a Dose Escalation Trial of TARA-002 in NMIBC Supporting Advancement into Phase 2 Clinical Development"
03/10/2023 8-K Regulation FD Disclosure  Interactive Data
03/08/2023 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits  Interactive Data
Docs: "Protara Therapeutics Announces Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update"
01/30/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Protara Therapeutics Announces Appointment of Patrick Fabbio as Chief Financial Officer"
01/05/2023 8-K Investor presentation
Docs: "PROTARA THERAPEUTICS, INC. CORPORATE PRESENTATION, JANUARY 2023"
11/03/2022 8-K Quarterly results
08/09/2022 8-K Quarterly results
07/18/2022 8-K Quarterly results
06/21/2022 8-K Quarterly results
06/09/2022 8-K Quarterly results
05/05/2022 8-K Quarterly results
03/09/2022 8-K Quarterly results
01/10/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Protara Therapeutics Announces Appointment of Jathin Bandari, M.D. as Chief Medical Officer"
11/04/2021 8-K Quarterly results
Docs: "Protara Therapeutics Announces Third Quarter 2021 Financial Results and Business Overview"
10/18/2021 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "CONSULTING AGREEMENT, DATED AS OF OCTOBER 16, 2021, BY AND BETWEEN THE COMPANY",
"SEPARATION AGREEMENT AND RELEASE"
10/12/2021 8-K Investor presentation
Docs: "Protara Therapeutics Announces FDA Clearance of Investigational New Drug Application for TARA-002 for the Treatment of Non-Muscle Invasive Bladder Cancer",
"PROTARA THERAPEUTICS, INC. CORPORATE PRESENTATION, OCTOBER 2021"
08/05/2021 8-K Quarterly results
06/10/2021 8-K Quarterly results
04/23/2021 8-K Quarterly results
04/19/2021 8-K Quarterly results
03/17/2021 8-K Quarterly results
03/03/2021 8-K Quarterly results
02/11/2021 8-K Quarterly results
02/02/2021 8-K Quarterly results
12/08/2020 8-K Entry into a Material Definitive Agreement
12/07/2020 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
11/17/2020 8-K Investor presentation
Docs: "Protara Therapeutics, Inc. Corporate Presentation, November 2020"
10/08/2020 8-K/A Quarterly results
09/23/2020 8-K Quarterly results
09/08/2020 8-K Investor presentation
Docs: "Protara Therapeutics Provides Comparability and U.S. Regulatory Updates for TARA-002 Supporting Advancement in Oncology and Rare Disease Indications",
"Protara Therapeutics, Inc. Corporate Presentation, September 2020"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy